Nutraveris
Thursday, April 17, 2014
Category : Non classé | Author : experts
Tags:

Commission Regulation (EU) No 212/2014 of 6 March 2014 amending Regulation (EC) No 1881/2006 as regards maximum levels of the contaminant citrinin in food supplements based on rice fermented with red yeast Monascus purpureus.
Following EFSA opinions on a possible concern for genotoxicity and carcinogenicity as regards citrinin, a maximum level of 2 000 μg/kg has been added in Regulation (EC) No 1881/2006 for food supplements based on rice fermented with red yeast Monascus purpureus.
Moreover ANSES (French Agency for Food, Environmental and Occupational Health & Safety) published an opinion on risks concerning red yeast rice in food supplements in March 2014.
ANSES received 25 reports of adverse reactions (mostly muscle and liver damage) likely to be linked to consumption of food supplement containing red yeast rice.
ANSES emphasizes that these products must not be used by patients taking statin-based medications, nor by those who had to stop taking statin-based medications due to adverse reactions. Vulnerable individuals (pregnant or breastfeeding women, children and adolescents, people over the age of 70 or suffering from certain pathologies, people who consume large amounts of grapefruit, etc.) should also avoid taking these supplements.

Leave a Reply